Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

NASDAQ:OVID

Overview | Financials
Company Name Ovid Therapeutics Inc.
Symbol OVID
Currency USD
Price 1.17
Market Cap 83,036,772
Dividend Yield 0%
52-week-range 0.68 - 4.1
Industry Biotechnology
Sector Healthcare
CEO Dr. Jeremy Max Levin Ba Zoology, Dphil, Mb Bchir
Website https://www.ovidrx.com

An error occurred while fetching data.

About Ovid Therapeutics Inc.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment

Related Stocks

Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc.

CTXR

0.548 USD

DarioHealth Corp. logo

DarioHealth Corp.

DRIO

1 USD

Assertio Holdings, Inc. logo

Assertio Holdings, Inc.

ASRT

1.35 USD

IO Biotech, Inc. logo

IO Biotech, Inc.

IOBT

1.19 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

1.71 USD

Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

CUE

0.565 USD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

Financials

Numbers are in millions USD

Numbers are in millions USD